This week the European Investment Fund took the first step in its ambitious new plan to unleash a wave of technology transfer across Europe. In doing so it endorsed a model pioneered in the UK.
French researchers have developed a cell therapy that could slash the risk of rejection after bone marrow grafts to under 5 per cent, and are looking for first-round funding.
A key distinction between physical and intellectual property is that the value of the latter is created as much by sharing it as by owning it. How to share it, between creator and enabler, is a particularly acute issue within the academic environment - as indicated by a recent, noteworthy debate on the subject in Sweden.
Finland wants to use its six months presiding over the EU to change innovation policy. It picks up the gauntlet at a meeting of competition ministers next week.
The Health Research Board of Ireland is to join the consortium of UK research funders developing a single gateway to the largest pool of patients in the world.
As the European Commission ponders the single European patent, the European Patent Office is under attack from national patent offices that want some of its functions.
The claim that European public opinion contributes to the technology gap between the US and Europe is invalid, according to the latest Eurobarometer survey.
The UK government has announced the formation of two further Enterprise Capital Funds, one more than it intended to set up in the first phase of the programme.
Economic disparity across Europe's regions can be linked directly to investment in research and development and adoption of information technologies, says an official report.
Carlos Moreira, co-founder and chairman of Swiss data-encryption firm WISekey, talks to Science|Business editor Richard L. Hudson on the travails of entrepreneurship.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.